Literature DB >> 8791778

CYP2D6 multiallelism.

A K Daly1, V M Steen, K S Fairbrother, J R Idle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8791778     DOI： 10.1016/s0076-6879(96)72024-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  38 in total

1.  CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.

Authors:  S Panserat; L Sica; N Gérard; H Mathieu; E Jacqz-Aigrain; R Krishnamoorthy
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 2.  Development of analytical technology in pharmacogenetic research.

Authors:  Ann K Daly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

3.  CYP3A5 phenotype-genotype correlations in a British population.

Authors:  Barry P King; Julian B S Leathart; Elaine Mutch; Faith M Williams; Ann K Daly
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

4.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

5.  A case of classical galactosemia: identification and characterization of 3 distinct mutations in galactose-1-phosphate uridyl transferase (GALT) gene in a single family.

Authors:  Ramandeep Singh; Gurjit Kaur; Babu R Thapa; Rajendra Prasad; Ketan Kulkarni
Journal:  Indian J Pediatr       Date:  2010-12-28       Impact factor: 1.967

6.  CYP3A phenotypes and genotypes in North Indians.

Authors:  Naushad Rais; Yogesh K Chawla; Krishan K Kohli
Journal:  Eur J Clin Pharmacol       Date:  2006-04-21       Impact factor: 2.953

7.  The CYP4502D6 *4 and *6 alleles are the molecular genetic markers for drug response: implications in colchicine non-responder FMF patients.

Authors:  Sinem Yalcıntepe; Ozturk Ozdemır; Coskun Sılan; Filiz Ozen; Ahmet Uludag; Ferhan Candan; Fatma Sılan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-03       Impact factor: 2.441

8.  The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population.

Authors:  Jun Tang; Jianzhu Zhao; Jungang Zhao
Journal:  Med Oncol       Date:  2014-08-22       Impact factor: 3.064

9.  Genetic variation in insulin-like growth factors and brain tumor risk.

Authors:  Stefan Lönn; Nathaniel Rothman; William R Shapiro; Howard A Fine; Robert G Selker; Peter M Black; Jay S Loeffler; Amy A Hutchinson; Peter D Inskip
Journal:  Neuro Oncol       Date:  2008-06-18       Impact factor: 12.300

10.  Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis.

Authors:  Gül Ozhan; Hakan T Yanar; Cemalettin Ertekin; Buket Alpertunga
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.